🔎 Trials Near Me

Почетна › Беркитов лимфом › Пенсилванија › Pittsburgh

Kliničke studije za Беркитов лимфом u gradu Pittsburgh, PA

6 studija za Беркитов лимфом traži učesnike na lokacijama u gradu Pittsburgh i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.

Zvanični tekst studije (na engleskom)

Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Тражи се учесникФаза 2
  • Children's Hospital of Pittsburgh of UPMC, Pittsburgh
Узраст од 1 до 30 · Оба пола · Ажурирано 12. 11. 2026. · NCT04546399

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

Тражи се учесникФаза 2
  • Children's Hospital of Pittsburgh of UPMC, Pittsburgh
365 Days · Оба пола · Ажурирано 27. 10. 2026. · NCT06317662

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

Тражи се учесникФаза 2
  • Children's Hospital of Pittsburgh of UPMC, Pittsburgh
366 Days – 46 Years · Оба пола · Ажурирано 27. 10. 2026. · NCT06124157

Testing the Safety of Anti-Cancer Drug, CX-5461 (Pidnarulex), in Treating Lymphoma With Specific Changes in the MYC Gene

Тражи се учесникФаза 1/2
  • UPMC Hillman Cancer Center, Pittsburgh
Узраст 18 и старији · Оба пола · Ажурирано 14. 10. 2026. · NCT07069699

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

Тражи се учесникФаза 3
  • Children's Hospital of Pittsburgh of UPMC, Pittsburgh
365 Days – 25 Years · Оба пола · Ажурирано 25. 8. 2026. · NCT03959085

Local Manufacture of CAR T-Cell Products for the Treatment of B-Cell Lymphoma and B-Acute Lymphoblastic Leukemia

Тражи се учесникФаза 2
  • AHN Cancer Institute - West Penn Hospital, Pittsburgh
Узраст од 18 до 79 · Оба пола · Ажурирано 13. 1. 2025. · NCT05281809

Studije za Беркитов лимфом u drugim gradovima

Ostale studije u gradu Pittsburgh

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.